RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
Nab-paclitaxel (Nab-P) in HER2-ve advanced breast cancer (ABC) patients (pts): From randomized trials to real-life setting: Results from GIM13 - AMBRA study
2017-01-01 Mustacchi, G; Cazzaniga, M; Bria, E; Bisagni, G; Biganzoli, L; Pronzato, P; De Placido, S; Romagnoli, E; Montemurro, F; Marchetti, P; De Laurentiis, M; Riccardi, F; Turletti, A; Michelotti, A; Natoli, Clara; Livi, L; Del Mastro, L; Donadio, M; Garrone, O; Giordano, M.
Nab-paclitaxel (Nab-P) in patients (pts) with HER2-ve advanced breast cancer (ABC): A focus on the elderly— Preliminary results of the GIM-13 AMBRA study
2018-01-01 Mustacchi, Giorgio; Pronzato, Paolo; D'Alonzo, Alessia; Mocerino, Carmela; Romagnoli, Emanuela; Garrone, Ornella; Blasi, Livio; De Laurentiis, Michelino; Michelotti, Andrea; Bologna, Alessandra; Giordano, Monica; Turletti, Anna; Montemurro, Filippo; De Placido, Sabino; Natoli, Clara; Taverniti, Cristiana; Biganzoli, Laura; Meattini, Icro; Marchetti, Paolo; Elena Cazzaniga, Marina
Neoadjuvant Chemotherapy for Surgically Staged IIIA N2 Non-Small Cell Lung Cancer (NSCLC) in the Elderly
2001-01-01 Iacobelli, Stefano; Irtelli, L; Martino, Mt; Natoli, Clara; Tinari, Nicola; Grassadonia, Antonino; Rocco, Sacco
PHER2-POSITIVE EARLY BREAST CANCER IN THE PRE-TRASTUZUMAB AND TRASTUZUMAB ERAS: A TRIPLE POSITIVE SUBGROUP ANALYSIS OF A MULTICENTER RETROSPECTIVE STUDY
2014-01-01 L., Pizzuti; Natoli, Clara; T., Gamucci; D., Sergi; L., Di Lauro; L., Moscetti; L., Mentuccia; A., Vaccaro; P., Trenta; P., Seminara; Ig, Rapposelli; V., Sini; D., Santini; I., Sperduti; P., Marchetti; P., Vici
PReal life experience with nivolumab in patients (pts) with advanced non-squamous NSCLC (nSq-NSCLC) exhibiting KRAS mutations: The Italian Expanded Access Program (EAP)
2017-01-01 Cappuzzo, F; Bidoli, P; Chiari, R; Chirco, A; Turci, D; Ardizzoni, A; Santoro, A; Natoli, Clara; Francini, G; Giordano, M; Borra, G; Defferrari, C; Livi, L; Berruti, A; Minelli, M; Ricevuto, E; Illiano, A; Puppo, G; Delmonte, A; Misino, A.
Predictive factors of response to neoadjuvant chemotherapy (NAT) in triple negative breast (TNBC) cancer patients: A restrospective multicenter observational study.
2015-01-01 Gamucci, Teresa; Mentuccia, Lucia; Vici, Patrizia; Iezzi, Laura; Sperduti, Isabella; Marchetti, Antonio A. s. t. o. n. e. . . Paolo; Pizzuti, Laura; Michelotti, Andrea; Sini, Valentina; Cassano, Alessandra; Ciancola, Fabrizio; Moscetti, Luca I.; Quadrini, Silvia; Landucci, Elisabetta; Magnolfi, Emanuela; Sergi, Domenico; Natoli, Clara
Predictive factors of response to neoadjuvant chemotherapy (NAT) in triple negative breast (TNBC) cancer patients: A restrospective multicenter observational study.
2017-01-01 Teresa, Gamucci; Lucia, Mentuccia; Patrizia, Vici; Iezzi, Laura; Isabella, Sperduti; Antonio, Astone; Paolo, Marchetti; Laura, Pizzuti; Andrea, Michelotti; Valentina, Sini; Alessandra, Cassano; Fabrizio, Ciancola; Moscetti, Luca I.; Silvia, Quadrini; Elisabetta, Landucci; Emanuela, Magnolfi; Domenico, Sergi; Natoli, Clara
Pretreatment neutrophil-lymphocyte ratio (NLR) predicted overall survival (OS) for metastatic melanoma, non-small cell lung cancer (NSCLC), renal cell carcinoma (RCC) patients who received monotherapy with immune checkpoint inhibitor as ipilimumab, nivolumab and pembrolizumab
2021-01-01 Di Marino, P; Primavera, Fc; Martino, Mt; Carella, C; Grassadonia, A; Tinari, N; Natoli, C; De Tursi, M
Relationship and predictive role of the dual expression of FGFR and IL8 in metastatic renal cell carcinoma (mRCC)
2015-01-01 Mosillo, C; Iacovelli, R; DE TURSI, Michele; Ciardi, A; Carella, C; Natoli, Clara; Naso, G; Corstesi, E
Relationship and predictive role of the dual expression of FGFR and IL8 in metastatic renal cell carcinoma (mRCC)
2015-01-01 Iacovelli, R; DE TURSI, Michele; Ciardi, A; Mosillo, C; Carella, Consiglia; Natoli, Clara; Naso, G; Enrico, C.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Nab-paclitaxel (Nab-P) in HER2-ve advanced breast cancer (ABC) patients (pts): From randomized trials to real-life setting: Results from GIM13 - AMBRA study | 2017 | Mustacchi, G; Cazzaniga, M; Bria, E; Bisagni, G; Biganzoli, L; Pronzato, P; De Placido, S; Romagnoli, E; Montemurro, F; Marchetti, P; De Laurentiis, M; Riccardi, F; Turletti, A; Michelotti, A; Natoli, Clara; Livi, L; Del Mastro, L; Donadio, M; Garrone, O; Giordano, M. | |
| Nab-paclitaxel (Nab-P) in patients (pts) with HER2-ve advanced breast cancer (ABC): A focus on the elderly— Preliminary results of the GIM-13 AMBRA study | 2018 | Mustacchi, Giorgio; Pronzato, Paolo; D'Alonzo, Alessia; Mocerino, Carmela; Romagnoli, Emanuela; Garrone, Ornella; Blasi, Livio; De Laurentiis, Michelino; Michelotti, Andrea; Bologna, Alessandra; Giordano, Monica; Turletti, Anna; Montemurro, Filippo; De Placido, Sabino; Natoli, Clara; Taverniti, Cristiana; Biganzoli, Laura; Meattini, Icro; Marchetti, Paolo; Elena Cazzaniga, Marina | |
| Neoadjuvant Chemotherapy for Surgically Staged IIIA N2 Non-Small Cell Lung Cancer (NSCLC) in the Elderly | 2001 | Iacobelli, Stefano; Irtelli, L; Martino, Mt; Natoli, Clara; Tinari, Nicola; Grassadonia, Antonino; Rocco, Sacco | |
| PHER2-POSITIVE EARLY BREAST CANCER IN THE PRE-TRASTUZUMAB AND TRASTUZUMAB ERAS: A TRIPLE POSITIVE SUBGROUP ANALYSIS OF A MULTICENTER RETROSPECTIVE STUDY | 2014 | L., Pizzuti; Natoli, Clara; T., Gamucci; D., Sergi; L., Di Lauro; L., Moscetti; L., Mentuccia; A., Vaccaro; P., Trenta; P., Seminara; Ig, Rapposelli; V., Sini; D., Santini; I., Sperduti; P., Marchetti; P., Vici | |
| PReal life experience with nivolumab in patients (pts) with advanced non-squamous NSCLC (nSq-NSCLC) exhibiting KRAS mutations: The Italian Expanded Access Program (EAP) | 2017 | Cappuzzo, F; Bidoli, P; Chiari, R; Chirco, A; Turci, D; Ardizzoni, A; Santoro, A; Natoli, Clara; Francini, G; Giordano, M; Borra, G; Defferrari, C; Livi, L; Berruti, A; Minelli, M; Ricevuto, E; Illiano, A; Puppo, G; Delmonte, A; Misino, A. | |
| Predictive factors of response to neoadjuvant chemotherapy (NAT) in triple negative breast (TNBC) cancer patients: A restrospective multicenter observational study. | 2015 | Gamucci, Teresa; Mentuccia, Lucia; Vici, Patrizia; Iezzi, Laura; Sperduti, Isabella; Marchetti, Antonio A. s. t. o. n. e. . . Paolo; Pizzuti, Laura; Michelotti, Andrea; Sini, Valentina; Cassano, Alessandra; Ciancola, Fabrizio; Moscetti, Luca I.; Quadrini, Silvia; Landucci, Elisabetta; Magnolfi, Emanuela; Sergi, Domenico; Natoli, Clara | |
| Predictive factors of response to neoadjuvant chemotherapy (NAT) in triple negative breast (TNBC) cancer patients: A restrospective multicenter observational study. | 2017 | Teresa, Gamucci; Lucia, Mentuccia; Patrizia, Vici; Iezzi, Laura; Isabella, Sperduti; Antonio, Astone; Paolo, Marchetti; Laura, Pizzuti; Andrea, Michelotti; Valentina, Sini; Alessandra, Cassano; Fabrizio, Ciancola; Moscetti, Luca I.; Silvia, Quadrini; Elisabetta, Landucci; Emanuela, Magnolfi; Domenico, Sergi; Natoli, Clara | |
| Pretreatment neutrophil-lymphocyte ratio (NLR) predicted overall survival (OS) for metastatic melanoma, non-small cell lung cancer (NSCLC), renal cell carcinoma (RCC) patients who received monotherapy with immune checkpoint inhibitor as ipilimumab, nivolumab and pembrolizumab | 2021 | Di Marino, P; Primavera, Fc; Martino, Mt; Carella, C; Grassadonia, A; Tinari, N; Natoli, C; De Tursi, M | |
| Relationship and predictive role of the dual expression of FGFR and IL8 in metastatic renal cell carcinoma (mRCC) | 2015 | Mosillo, C; Iacovelli, R; DE TURSI, Michele; Ciardi, A; Carella, C; Natoli, Clara; Naso, G; Corstesi, E | |
| Relationship and predictive role of the dual expression of FGFR and IL8 in metastatic renal cell carcinoma (mRCC) | 2015 | Iacovelli, R; DE TURSI, Michele; Ciardi, A; Mosillo, C; Carella, Consiglia; Natoli, Clara; Naso, G; Enrico, C. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 1.5 Abstract in rivista 49
Data di pubblicazione
- 2020 - 2021 1
- 2010 - 2019 40
- 2000 - 2009 4
- 1991 - 1999 4
Rivista
- ANNALS OF ONCOLOGY 16
- JOURNAL OF CLINICAL ONCOLOGY 12
- ANTICANCER RESEARCH 4
- CANCER RESEARCH 2
- CANCER RESEARCH 2
- EUROPEAN JOURNAL OF CANCER 2
- EUROPEAN UROLOGY. SUPPLEMENTS 2
- JOURNAL OF TRANSLATIONAL MEDICINE 2
- TUMORI 2
- AMERICAN JOURNAL OF CLINICAL ONCO... 1
Keyword
- Advanced Breast Cancer Luminal HE... 1
- anti-PD1/PD-L1 inhibitors 1
- breast cancer TTC 1
- cancer 1
- cncer 1
- enzalutameide prostate 1
- enzalutamide 1
- family history of cancer 1
- flu vaccine 1
- immune-checkpoint inhibitors (CKI) 1
Lingua
- eng 34
- ita 2
Accesso al fulltext
- no fulltext 49